A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes

Clinical and Experimental Immunology

Volumn 133, Issue 1, 2003, Pages 30-37

  Lopez B ^a   Aguilar, D ^b   Orozco, H ^b   Burger, M ^c   Espitia, C ^d   Ritacco, V ^a,b,c   Barrera, L ^a   Kremer, K ^c   Hernandez Pando, Rogelio ^b   Huygen, K ^d   Van Soolingen, D ^c  

^a National Administration of Laboratories and Institutes of Health   (Argentina)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASIA; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BCG VACCINATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC VARIABILITY; GENOTYPE; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INCIDENCE; INFECTION PREVENTION; LABORATORY; LUNG; MALE; MORAXELLA; MORTALITY; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STRAIN DIFFERENCE; SURVIVAL; TISSUE DISTRIBUTION; TUBERCULOSIS; USSR;

ANIMALS; BCG VACCINE; COLONY-FORMING UNITS ASSAY; CYTOKINES; DISEASE SUSCEPTIBILITY; GENOME, BACTERIAL; GENOTYPE; LUNG; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TUBERCULOSIS, PULMONARY;

EID: 0038496713     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02171.x     Document Type: Article

References (41)

1. Bloom BR, Murray CJ. Tuberculosis commentary on a reemergent killer. Science 1992; 257:1055-64.
2. Nardell EA. Environmental control of tuberculosis. Med Clin North Am 1993; 77:1315-34.
3. Hernandez-Pando R, Pavon L, Arriaga K, Orozco H, Madrid-Marina V, Rook G. Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte. Infect Immun 1997; 65:3317-27.
4. Hill AV. The immunogenetics of human infectious diseases. Annu Rev Immunol 1998; 16:593-617.
5. Bellamy RC, Ruwende TC, Corrah TKP, McAdams KP, Whittle HC, Hill AV. Variation in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338:640-4.
6. Stead WW. Genetics and resistance to tuberculosis. Could resistance be enhanced by genetic engineering? Ann Intern Med 1992; 116:937-41.
7. Kramnik I, Dietrich WF, Demant P, Bloom BR. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Nat Acad Sci 2000; 97:8560-5.
8. Chan X, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated macrophages. J Exp Med 1992; 175:1111-22.
9. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15:323-50.
10. Seah GT, Scott GM, Rook GAW. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 2000; 181:385-9.
11. Wangoo A, Sparer T, Brown IN et al. Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous disease. J Immunol 2001; 166:3432-9.
12. Hernandez-Pando R, Orozco EH, Sampieri A et al. Correlation between kinetics of Th1/Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 1996; 89:26-33.
13. Hernandez-Pando R, Orozco EH, Arriaga AK et al. Analysis of the local kinetics and localization of interleukin 1α, tumor necrosis factor α and transforming growth factor β during the course of experimental pulmonary tuberculosis. Immunology 1997; 90:607-17.
14. Hernandez-Pando R, Schön T, Orozco EH, Serafín J, Estrada-Garcia I. Expression of nitric oxide synthase and nitrotyrosine during the evolution of experimental pulmonary tuberculosis. Exp Toxicol Pathol 2001; 53:257-65.
15. Valway SE, Sanchez MPC, Shinnick TF et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N Engl J Med 1998; 338:633-9.
16. Caminero J, Pena MJ, Campos-Herrero MI et al. Epidemiologic evidence for the spread of a Mycobacterium tuberculosis strain of the 'Beijing' genotype on Gran Canaria Island. Am J Respir Crit Care Med 2001; 164:1165-70.
17. Manca C, Tsenova L, Barry C et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 1999; 162:6740-6.
18. Manca C, Tsenova L, Bergtold A et al. Virulence of a Mycobacterium tuberculosis isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β. Proc Nac Acad Sci 2001; 98:5752-7.
19. Bishai W. Tuberculosis transmission - rogue pathogen or rogue patient? Am J Respir Crit Care Med 2001; 164:1104-5.
20. Van Soolingen D. Use of DNA fingerprinting in the epidemiology of tuberculosis. PhD thesis. Utrecht University, 1996.
21. Van Soolingen D, Qian L, de Haas PEW et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J Clin Microbiol 1995; 33:3234-8.
22. Kremer K, van Soolingen D, Frothingham R et al. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol 1999; 37:2607-18.
23. Van Embden JDA, Cave MD, Crawford JT et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standarized methodology. J Clin Microbiol 1993; 31:406-9.
24. Qian L, van Embden JDA, van der Zanden AGM, Weltevreden EF, Duanmu H, Douglas JT. Retrospective analysis of the Beijing family of Mycobacterium tuberculosis in preserved lung tissues. J Clin Microbiol 1999; 37:471-4.
25. van Soolingen D, de Haas PEW, Hermans PW, Groenen PM, van Embden JD. Comparison of various repetitive DNA elements as genetics markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J Clin Microbiol 1995; 33:3234-8.
26. van Soolingen D, Hoogenboezem T, de Haas PEW et al. A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol 1997; 47:1236-45.
27. Huygen K, Abramowicz D, Vandenbussche P et al. Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect Immun 1992; 60:2880-6.
28. Hernandez-Pando R, Pavon L, Orozco EH, Rangel J, Rook GAW. Interactions between hormone-mediated and vaccine mediated immunotherapy for pulmonary tuberculosis in BALB/c mice. Immunology 2000; 100:391-8.
29. Chomzynski PA. Reagent for the single step simultaneous isolation of RNA, DNA and proteins from cells and tissue samples. Biotechniques 1993; 15:532-5.
30. Tanghe A, Lefèvre P, Denis O et al. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J Immunol 1999; 162:1113-9.
31. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russel DG, Orme I. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993; 178:2243-7.
32. Anh DD, Van Borgdorff MWLN, Lan NTN, van Gorkom T, Kremer K, van Soolingen D. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 2000; 6:302-5.
33. Marttila HJ, Soini H, Vyshnevskiy BI et al. Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and line probe assay. Scand J Infect Dis 1998; 30:129-32.
34. Portaels F, Rigouts L, Bastian I. Addressing multi-drug resistant tuberculosis in penintentiary hospitals and in the general population of the former Soviet Union. Int J Tuberc Lung Dis 1999; 3:582-8.
35. Narvskaya OV, Mokrousov IV, Otten TF, Vyshnevskiy BI. Genetical marking of Mycobacterium tuberculosis polyresistant strains isolated in the North-West part of Russia. Probl Tuberk 1999; 3:39.
36. Bifani PJ, Plikaytis BB, Kapur V et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996; 275:452-7.
37. Van Crevel R, Nelwan RHH, de Lenne W et al. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg Infect Dis 2001; 7:880-3.
38. Daffe M, McNeil M, Brennan P. Novel type specific lipooligosacharides from Mycobacterium tuberculosis. Biochemistry 1991; 30:378-88.
39. Pfyffer GE, Auckenthaler R, van Embden JDA, van Soolingen D. Mycobacterium canetti, the smooth variant of M. tuberculosis, isolated from a Swiss patient exposed in Africa. Emerg Infect Dis 1998; 4:631-4.
40. Gerome P, Koeck JL, Bernatas T, Fabre M, Herve V, Vanerot A, Vincent V. Four new cases of lymph node tuberculosis due to M. tuberculosis subsp. canetti in Djibouti, Horn of Africa. Proceedings of the 21st Annual Congress of the European Society of Mycobacteriology, Vienna, Austria, 2000.
41. Schaefer WB, Davies CL, Cohn ML. Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice. Am Rev Respir Dis 1970; 102:499-506.